Ir a las Transacciones
Salud

Optibiotix Health has successfully raised US$1.3 million though a placing of new shares

Optibiotix Health Plc has completed a fundraising to continue the commercialization of its products with corporate and large retail partners, with a particular focus on the company’s SweetBiotix©.

OptiBiotix Health is a life sciences company operating in one of the most progressive areas of biotechnological research. Developing technologies that modulate the human microbiome – the collective genome of the microbes in the body – OptiBiotix identifies and develops microbial strains, compounds and formulations for use in food ingredients, supplements and active compounds that can impact on human physiology, deriving potential health benefits. With an established pipeline of microbiome modulators, the OptiBiotix team is working in the prevention and management of chronic lifestyle diseases including obesity, hypercholesterolemia and lipid profiles and diabetes.

Oaklins Cavendish’s sister firm finnCap, based in the UK, advised Optibiotix Health on its equity fundraising.

Contáctese con el equipo de la transacción

 Geoff  Nash

Geoff Nash

Director
Londres, Reino Unido
Oaklins Cavendish

Transacciones relacionadas

Xeros Technology Group has completed a placing, subscription and retail offer
Maquinaria y Componentes Industriales

Xeros Technology Group has completed a placing, subscription and retail offer

Xeros Technology Group plc has raised funds to drive forward its commercialization strategy.

Ver más
PCI Pal has completed an equity raise
Servicios Financieros | TMT

PCI Pal has completed an equity raise

PCI Pal has completed a fundraising. Funds will be allocated towards several key areas, with a significant portion directed towards supporting its continued expansion in the US, focusing on marketing efforts, product marketing and enhancing engagement with key partners.

Ver más
Prestige Inhome Care has found a long-term strategic partner
Salud

Prestige Inhome Care has found a long-term strategic partner

Prestige Inhome Care has received a growth capital investment from Yorkway Private. The newly formed partnership will provide growth capital for geographic expansion, increasing Prestige’s range of services and potential future acquisitions. The investment in Prestige is in line with Yorkway’s mandate to invest in leading Australian mid-market companies with strong management teams, backed by significant growth tail winds, as is the case in the aged care industry.

Ver más